Guangji Pharmaceutical Industry: Obtain the registration certificate for hydroxocobalamin tablets.

Guangji Pharmaceutical announced that it has recently received the "Drug Registration Certificate" for Mecobalamin Tablets issued by the National Medical Products Administration. The drug's acceptance number is CYHS2402791, the dosage form is tablets, and the registration classification belongs to the chemical drug category 4. The approval number is National Medicine Standard H20263341, mainly used for the treatment of peripheral nerve diseases. This approval marks a significant progress in the company's product layout in the field of peripheral nerve disease treatment, and the company will promote production and market supply. However, drug production and sales are affected by factors such as policies and market environment, leading to uncertainties.